CD8A and autoimmune thrombocytopenic purpura: However, in the first decade of the 21st century, there have been some breakthroughs in the exploration of the pathogenesis and treatment of ITP, such as CD8+ T cells and TPO-RAs, and these documents were significant for understanding the lineage and direction of the field (3, 9).